Cordero, ElisaBulnes Ramos, ÁngelAguilar Guisado, ManuelaGonzález Escribano, FranciscaOlivas, IsraelTorre Cisneros, JuliánGavaldà, JoanAydillo, TeresaMoreno, AsunciónMontejo, MiguelFariñas, María CarmenCarratalà, JordiMuñoz, PatriciaBlanes, MarinoFortún, JesúsSuarez Benjumea, AlejandroLópez Medrano, FranciscoRoca, CristinaLara, RosarioPérez Romero, Pilar2021-02-232021-02-232020-10-06https://hdl.handle.net/2445/174213Introduction: Our goal was to study whether influenza vaccination induced antibody mediated rejection in a large cohort of solid organ transplant recipients (SOTR). Methods: Serum anti-Human Leukocyte Antigen (HLA) antibodies were determined using class I and class II antibody-coated latex beads (FlowPRA(TM)Screening Test) by flow cytometry. Anti-HLA antibody specificity was determined using the single-antigen bead flow cytometry (SAFC) assay and assignation of donor specific antibodies (DSA) was performed by virtual-crossmatch. Results: We studied a cohort of 490 SOTR that received an influenza vaccination from 2009 to 2013: 110 (22.4%) received the pandemic adjuvanted vaccine, 59 (12%) within the first 6 months post-transplantation, 185 (37.7%) more than 6 months after transplantation and 136 (27.7%) received two vaccination doses. Overall, no differences of anti-HLA antibodies were found after immunization in patients that received the adjuvanted vaccine, within the first 6 months post-transplantation, or based on the type of organ transplanted. However, the second immunization dose increased the percentage of patients positive for anti-HLA class I significantly compared with patients with one dose (14.6% vs. 3.8%;P= 0.003). Patients with pre-existing antibodies before vaccination (15.7% for anti-HLA class I and 15.9% for class II) did not increase reactivity after immunization. A group of 75 (14.4%) patients developedde novoanti-HLA antibodies, however, only 5 (1.02%) of them were DSA, and none experienced allograft rejection. Only two (0.4%) patients were diagnosed with graft rejection with favorable outcomes and neither of them developed DSA. Conclusion: Our results suggest that influenza vaccination is not associated with graft rejection in this cohort of SOTR.10 p.application/pdfengcc by (c) Cordero et al., 2020http://creativecommons.org/licenses/by/3.0/es/CitomegalovirusInfluenzavirusVacunes antivíriquesCytomegalovirusesInfluenza virusesViral vaccinesinfo:eu-repo/semantics/article2021-02-08info:eu-repo/semantics/openAccess33123119